The "Peripheral Access Utilizing Sonographic Evaluation" Study (PAUSE)
調査の概要
状態
条件
詳細な説明
The purpose of this study is to reduce, by using the ultrasound guided technique, the minor surgical procedures that might be required to deliver fluids into the blood of critically ill patients simply because the patients' veins cannot be located through the manual technique.
The ultrasound assisted technique will increase accessibility to small veins that might be missed via the manual technique. The technique of using an ultrasound machine to assist the administration of fluids into a patient's veins is called ultrasound guided peripheral intravenous access (USGPIVA), while the traditional technique that uses only sight and touch to locate a patient veins without machine assistance is called the traditional landmark technique (TLT). The investigators will compare the effectiveness of USGPIVA with TLT in terms of reducing complications and costs.
研究の種類
段階
- 適用できない
連絡先と場所
研究場所
-
-
New Jersey
-
Hackensack、New Jersey、アメリカ、07601
- Hackensack University Medical Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- The patient is >= 21 years of age
- Adult critically ill patients in CCU and MICU requiring short peripheral intravenous access
- The patient has been identified as difficult intravenous access (DIVA), defined as at least two failed blind sticks in the antecubital fossa or more distal upper arm veins
- The patient does not otherwise require a CVC
Exclusion Criteria:
The patient has a PICC line on the same side as IV placement and has the following:
- Has a condition poses risk for DIC, inadequate flow, or infection.
- Has been identified as a site for "Save the Vein" protocol implementation, unless permission is otherwise obtained by the patient's physician.
- Has a hemodialysis fistula in place on that upper arm side.
The patient is expected to require therapeutic agent or procedure that necessitates central venous access such as:
- central venous monitoring
- Total Parenteral Nutrition
- Antibiotic requiring central venous access
- Chemotherapy
- Vesicants
- Medications pH less than 5 or more than 9
- Medications of glucose concentrations above 10%
- Solution with protein concentrations above 5% (Vascular Access Management, n.d.)
- The patient already has a central venous catheter access, for reasons other than DIVA, through which therapy can be infused
- The patient has renal disease and a "Save The Vein" order is anticipated or pending (serum creatinine >2mg/dL and GFR <20) for one of the patient's arms, unless permission is otherwise obtained by the patient's physician
- The patient has a bleeding disorder, unless permission is otherwise obtained by the patient's physician
- The clinician believes the patient is not a good fit for the study or that the procedure is not appropriate for patient at the given moment
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Landmark Technique Attempt
Patients will undergo an additonal TLT attempt
|
|
|
実験的:USGPIVA Technique Attempt
Patients will be offered a USGPIVA attempt after two failed attempts using the traditional landmark technique (TLT)
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Reduction in number of minor surgical procedures that may be required to deliver fluids into the blood of critically ill patients by using the ultrasound guided technique
時間枠:1 Day
|
1 Day
|
協力者と研究者
捜査官
- 主任研究者:Nancy Van Buitenen, MSN, APN, RN、Hackensack UMC
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- Pro 2921
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。